N
Google TrendANNA BONDAR (200+) — October 11, 2026: Lilli Tagger vs Nikola Bartunkova: Set 1 Winner Prediction Market
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:anna bondar200+natanael cano100+green card500+power outage near me10000+india2000+sony playstation1000+loki100+hubert hurkacz200+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "New data showcase promise" (30 stories)

Top Headline Story

An ‘off-the-shelf’ CAR-T therapy from Adicet shows promise against lupus
Lead StoryBioPharma Divetech
Sep 28

An ‘off-the-shelf’ CAR-T therapy from Adicet shows promise against lupus

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQUHRYZHhuZEx1QW5BSC1BVTdmQm5fVm1TdkloQ3I5RnFCUU9jTFA1NnhYaEMyR0hCX2JfOXJEMGpEUFRPWWc2aHFoaUZWaXJOTVpHWUFqWE95Tk5OU2pmSjZEMlJCTm55YjJNbjJYNnd0N1ptUklieXoxS0VlMlNybE04WjQwdm1mVTlJYXVlZFpOa21mTXFLc1l3?oc=5" target="_blank">An ‘off-the-shelf’ CAR-T therapy from Adicet shows promise against lupus</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
200+21m ago

anna bondar

October 11, 2026: Lilli Tagger vs Nikola Bartunkova: Set 1 Winner Prediction Market

Filter stories
100+21m ago

natanael cano

Padres de Natanael Cano rompen el silencio tras retiro del cantante: "Es por el bien de nuestro hijo"

Filter stories
500+31m ago

green card

Vance says Microsoft replaced laid-off workers with foreign hires. Here’s what the visa data shows

Filter stories
10000+31m ago

power outage near me

LIVE | Atlanta weather: Power outages, tree damage remain as storm threat moves east

Filter stories

Search Results for "New data showcase promise"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Union Minister Shri Ashwini Vaishnaw Launches World Bank Group’s ‘World Development Report 2026: The Promise of Artificial Intelligence’ in New Delhi
PIBtech

Union Minister Shri Ashwini Vaishnaw Launches World Bank Group’s ‘World Development Report 2026: The Promise of Artificial Intelligence’ in New Delhi

<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE5JSVE3RC1Ta2c3VXJ2YVRkY005NVhFMlFqbHNjZFJpZmJVMi00SVlFUjNzVUszT2c0NkJCTkZTMW9QalhlblhQakRCNTEtRFZDeF9FZ3RlajRLQVZfcW1XZVE1NHZ5VTRI?oc=5" target="_blank">Union Minister Shri Ashwini Vaishnaw Launches World Bank Group’s ‘World Development Report 2026: The Promise of Artificial Intelligence’ in New Delhi</a>  <font color="#6f6f6f">PIB</font>

Read Full StoryMore like this
Novartis wagers almost $8B on a Chinese biotech’s RNA drugs
BioPharma Divetech

Novartis wagers almost $8B on a Chinese biotech’s RNA drugs

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxORWhYRVZYSWVlcnZUamdnVVVRZkktSE9YMEpwSnY1cGNRcTl6MkxnMk9aTzRUOUN6VDhjVWdVTVE0WmE5QlQzWThBRkF1NDBhYi1QNmJ3Q2FOQ2NtRzRTdV8tWFQ5RDZUVnFNYUdPVm9SR1NPdXBXQ0wzTXY4eDFDb3dGNGVpa2lHbVN4am5xNkE?oc=5" target="_blank">Novartis wagers almost $8B on a Chinese biotech’s RNA drugs</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
ai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’
BioPharma Divetech

ai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPaVhkX2xHaFZlMC1LcDZQa2JoRWw2dlNBQThfY2RBZUVCemtwQmczcHhPRWcxMUtPZXItX0U4dG9NM2xtTVRUV1VPNXcwT0Q0NHhILUlGdnZKMEJlSTR1MkhXSExjSUNRNmFwUzF0S0hRUWpnUHVMNjZzdEtWWkxpYi11ODhDV25HczFYWWJHN01KeTg?oc=5" target="_blank">ai3Bio, built from two biotechs, pursues a different path to an ‘immune reset’</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Bumper showcase of new products promised for PATS 2026
Pet Business Worldgeneral

Bumper showcase of new products promised for PATS 2026

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxNelRqUUFQaTFSVGc2V3VzMXpWanRpWEFBdklYSFU4MzZFcU53Ylp6NHhycFBmcmZnWGVSalRoNTlvYzFFSXNUR2lOUEVmSGk4a3RJTDZscmx4RHh2Rjk2LU91R296TUt6Mm9KbjdDOWxySDZ1V0hlS182Nmt3ek9iNHkyOVlwT0J3aGh6b1kwY1d2Szl4bERaNFVhVjZYcE5id2VQWjhTSUdXZktCeGJuMk1VSEdKN0ZEM2RV?oc=5" target="_blank">Bumper showcase of new products promised for PATS 2026</a>  <font color="#6f6f6f">Pet Business World</font>

Read Full StoryMore like this
Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts
BioPharma Diveworld

Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOSzYxR2NaVDhZZTlCNnpfZkdZNjNJSTcyT28zNHBSTHMxYkFTSzdKT3R4dEpSV2VFdEFyTmVUMlRKQkN0RGpkX0hUMU1iWDVrRzhVWnZHeXFnUGpDQ0k3SnlxWTVvdEEtYzhLTjNmVTZSeXlDcDlyWjJ6RXJkMGRnZFhNVWtQbEU0WGNjQjlGZUFkNG83WU5Pc2xOT0lhY3hYb29JaTlpNlB5bDgw?oc=5" target="_blank">Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
EMPOWER-Lung 1 Trial Data Showcase Promise of Cemiplimab in NSCLC
AJMCworld

EMPOWER-Lung 1 Trial Data Showcase Promise of Cemiplimab in NSCLC

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxOMHVZd3N3ckJzY0h4Ym9MdnpvSm40bjZmWTU5bEFRX2pIMDZTbExEWUFOcjlwZjVzWFZjTXgxeUFDWWZKMnJZNEh4UmlwZi1NM0p2UHBMSmMtVnJUZDdNNjk2a2kwbjhNQjc2amRpT1A0NTNyY1dDTmNLX0l6eE1lRDlfMmJKbzA5SEpKdUJlaWFMNXVFS1E?oc=5" target="_blank">EMPOWER-Lung 1 Trial Data Showcase Promise of Cemiplimab in NSCLC</a>  <font color="#6f6f6f">AJMC</font>

Read Full StoryMore like this
Mayo Clinic Platform_Accelerate Showcase celebrates promise of health tech innovation for improving patient care
Florida Hospital News and Healthcare Reporttech

Mayo Clinic Platform_Accelerate Showcase celebrates promise of health tech innovation for improving patient care

<a href="https://news.google.com/rss/articles/CBMi8wFBVV95cUxNUGQyMG1MaVhKYm05TW1XOG1VX0lrZWEyT0huS19JQ2dmdmhQZDQweC1tUnNxU1J2UlNlSzdkNHlXT0ljeHFBNjZwVGQ0bWpXSzhfNmVaaXgyM0ZLbjRpUGhrNzZHOVpHZV9ENXFld2M5NWRBQnh6NThad3VGZUVCU2hPams0S1hkSVlLaWpoX3kxdFNTR2tYamthUHBfXzVNRTAxN204Zm90a3VUY3UtQ1NtS0R3OVpKZzN0M05yQlZSZ2UtTGx2aVNoSnJIa1lnWnJTdmxDYWNfQWNBdW5ycURNMkFVdnpEUkRFaU00WXlQdXc?oc=5" target="_blank">Mayo Clinic Platform_Accelerate Showcase celebrates promise of health tech innovation for improving patient care</a>  <font color="#6f6f6f">Florida Hospital News and Healthcare Report</font>

Read Full StoryMore like this
Mayo Clinic Platform_Accelerate Showcase celebrates promise of health tech innovation for improving patient care
Mayo Clinic News Networktech

Mayo Clinic Platform_Accelerate Showcase celebrates promise of health tech innovation for improving patient care

<a href="https://news.google.com/rss/articles/CBMi8AFBVV95cUxNMHpWdDNIaVpacGl4UXEzUmdRbEotN0hUTmU1ckVRbnVCNjdHTkF2VU1lMVRPMEZ4c2NQYUM4eER2U1pockU1eEt1VzhiVTNUTXVJdWFuamJWcnQxQ0UxMUdKMW1Qd1NYRTBXWjdhdVRXS1F2YzZYZTNmZFRJRDZaQ1VINFVhRjc2MVFlY0RkbDlsVGUwVjQ5V3kxRFd3TS1sV04tXzFxLXRETGRUZjBoVWRTSUd2TGpzc3R0RzlOZTktMXZJYmxqdThBWWRTUGRISXUzU2t3QVA5LV9KZjZSb0VHMU9oRldwdnUyTlVfckU?oc=5" target="_blank">Mayo Clinic Platform_Accelerate Showcase celebrates promise of health tech innovation for improving patient care</a>  <font color="#6f6f6f">Mayo Clinic News Network</font>

Read Full StoryMore like this
Translational science showcase highlights RNA’s promise to improve human health
Brown Universityscience

Translational science showcase highlights RNA’s promise to improve human health

<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE04VllrT1V2ZFF3Y240S0FoWlZwemdQeVRkd293bmd5ZHNlVVFHYW1TcDFqcE9mTXdRa3VUNGQzRndrS3Qzb2w2cGc4aVN0aFRyZnUyQWthMWc5YlBXcWNiNUx6WmdxeXdXRU9zU0FRVzFUOGVPM0JUZXdB?oc=5" target="_blank">Translational science showcase highlights RNA’s promise to improve human health</a>  <font color="#6f6f6f">Brown University</font>

Read Full StoryMore like this
CROI 2025 Shows the Promise of Research at its Best
avac.orggeneral

CROI 2025 Shows the Promise of Research at its Best

<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFAwNTBEZkctRDdzUC1iLTFPUl9ETURaMHdQb0MyT0FDeTJaalFjdnZwU3R6RnQ2X1FDa1hhNkxMd21CMkpORVdCaElqc3FkdERhMFF5Mk8xZXZDeUw0NC1aeA?oc=5" target="_blank">CROI 2025 Shows the Promise of Research at its Best</a>  <font color="#6f6f6f">avac.org</font>

Read Full StoryMore like this
UAMS Showcase Celebrates BioVentures-Supported Research with Commercial Promise
UAMS Newsgeneral

UAMS Showcase Celebrates BioVentures-Supported Research with Commercial Promise

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxPNlAtQzUxUmsyU1JwQ2o0U1BnZ29PZmlSSmF4aUFaZS0zRnZhcXM1RjBaTGppWFNub2lmeXV1eHRtNW1HX2liNFZVeHZfamVnOG5yOThGY0E2OXAwUVhMcHp4TUJ4NncxVDUxMHRXbGhwbjhFbVNrUDVreF9mUjBUUFNGbDZvVnZ4N3FCeTIzM185UUwzZDVIQ3hScjJHZWxKSHF4dUd6MXNKOHowdXprU1FrQQ?oc=5" target="_blank">UAMS Showcase Celebrates BioVentures-Supported Research with Commercial Promise</a>  <font color="#6f6f6f">UAMS News</font>

Read Full StoryMore like this
Investigational Assay Shows Promise as Prognostic Tool for Prostate Cancer
Targeted Oncologygeneral

Investigational Assay Shows Promise as Prognostic Tool for Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxQZU9PUDZlMDZLVExJQ1VwRDhLYzZ4bnNBNVYtLU9aME1Mc3RjR2pEZGdRbzJzRFZJZ2dfd2drcGRwNk9pdFNYWTBxVGlwR00zOTVqQWRVTnd3VlVVRUtaTTVIQTg3S3hnWTRzdjBBLWdSd0syWXR5U0t6QnhGNlZ4bTBJV0RzbkhxUnByS0VkSDl5dVQtWkVsS1RxMDZOSHh2NjRmb294ZThZUms?oc=5" target="_blank">Investigational Assay Shows Promise as Prognostic Tool for Prostate Cancer</a>  <font color="#6f6f6f">Targeted Oncology</font>

Read Full StoryMore like this
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns
BioPharma Diveworld

Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxObjBCQUgxNnhlWERZU3l0U0NTb2lycy04TFFMdThBbHpHQ2JheWJnUGQ3OGppX3NTQ1FLeVpOQWpndDQ2OGlFZG84Y3M5djcyRDRhZmJmZldsajVRQXVKek50RUxDZ1ZPMkoydnB1NENDWjhObzJzdWZ4ZWJ1ZFBEbE9UOFQ4Z0NvTnJtRmg4NER2YUpKMk1sSDZCM1h2Q1FnVnc?oc=5" target="_blank">Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Boulevard starts up with $65M to pursue targeted autoimmune drugs
BioPharma Diveworld

Boulevard starts up with $65M to pursue targeted autoimmune drugs

<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxNTzJ2Y3lfQkNjdThXT2F5SGlMWG9DS1I2N3VrWFpMeWRpTkhSMVZsSDM5bkFpaURsQl9LZDZIS2JKQnlScHBUOWp5V1JhNkZ6U180RXluSXRUOFQ4LWc3OTVJZ1JnSC12eDNqU2VDLS10dk93Y0N5cVVhX2JaVVVYbGh4ZEJVOHRzZS1r?oc=5" target="_blank">Boulevard starts up with $65M to pursue targeted autoimmune drugs</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
UCB to acquire Candid in $2.2B bet on bispecifics for autoimmune diseases
BioPharma Diveworld

UCB to acquire Candid in $2.2B bet on bispecifics for autoimmune diseases

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxNV3BZMWNYTnRoU2xUc2FzS1BFRWlJNHZGSTZ6bHgzVVQ1RVR0WnNDWUhTUG5jN0t5VW8tVExsQUd6ZE5wUEFONENIVHdjSlBCR21pczg5TVl3VXBmcDhLanF4NDdCM1VpVVhYQllmZmJzS3NPYlV2QVR6N2RYdlh0d3NRcDZWN0wtX3RLdExuZVhDcTNWTGdEWjJzVzdHaGlWOXk2UVhR?oc=5" target="_blank">UCB to acquire Candid in $2.2B bet on bispecifics for autoimmune diseases</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
New data showcase promise, growing pains of CAR-T in autoimmune disease
BioPharma Divetech

New data showcase promise, growing pains of CAR-T in autoimmune disease

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNcjhPOUxuT2RJX09GbWdCUF9aeVk5Qmk4c0lBUGh1TmxVU1RsN1lvZFlXdXphd2lFOS01RFNnbkFLV2ExclNoekpISVA5OC1rcFBaSFdRYzhZanIzbkRWLWsxZFJ6QUhZNVFXUlAyS2ljQnlYczdSSUdoUURJLWx1QVkwazR6WlBBMkNYdDhCbVlBWnh5dGF5S1hqZWtYdw?oc=5" target="_blank">New data showcase promise, growing pains of CAR-T in autoimmune disease</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Gilead, with Ouro deal, wagers $1.7B on bispecifics for autoimmune diseases
BioPharma Diveworld

Gilead, with Ouro deal, wagers $1.7B on bispecifics for autoimmune diseases

<a href="https://news.google.com/rss/articles/CBMiggFBVV95cUxOcWhyZHBEaXp2MGYzTDk2NzFJMmJ0Z0FJRGJxeFE4OFpJejlteFlzZUlqeThWUHNCWGpEOVY1cVBBQUtKcXlQelZvU2gxa21ta0lwaTkybjI0emFqektDN1BGQ28wY2VhMEVNQmdjZFpQWFJOcU5YdmRjRngyOUFoclZR?oc=5" target="_blank">Gilead, with Ouro deal, wagers $1.7B on bispecifics for autoimmune diseases</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Lilly buys ‘in vivo’ CAR-T maker Orna, extending streak of genetic medicine deals
BioPharma Divegeneral

Lilly buys ‘in vivo’ CAR-T maker Orna, extending streak of genetic medicine deals

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxQTUVhd0RKX0pObm16cTVyQVBlalJPcXhaVWU5R0pqb0hrX1hKcWN5UW5DNEprQUxJajBaMDd4SXVoZEJNc1llWkxkS29xeS04aGlkaTIydV9DZFJpOXplZjJxMGR4MUYtbmR6NXU1elhqUElacGhpMDFFbl9YQ2lDOVMtNU0tZG5DU0lnUE4tdjhJa0pqTWpxNA?oc=5" target="_blank">Lilly buys ‘in vivo’ CAR-T maker Orna, extending streak of genetic medicine deals</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Kyverna to seek first clearance of a CAR-T therapy for autoimmune disease
BioPharma Diveworld

Kyverna to seek first clearance of a CAR-T therapy for autoimmune disease

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPaldEMFFFMzVOV3IzU09vR2piOTJ6Q0pVdjFPNm9fa3FMakxVQ3FOY3ZZcXNnNWhRYUVXdjBvS3NpR2tuQ1dab3BUMFp5ZlpjRzVzaGNkUFdSMEtGdTIxUVVYWlUtTmNGOHpxbVVJbkN3eFNfNzZaZ0JSXzF6S00wT01JSjlMQ3otRl9GNnFDWVVzbm44RVZRU29MZEhBb0lIRUtWc25Ucw?oc=5" target="_blank">Kyverna to seek first clearance of a CAR-T therapy for autoimmune disease</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
ADC FG-3246 May Show Promise in Advanced Prostate Cancer
Cure Todaygeneral

ADC FG-3246 May Show Promise in Advanced Prostate Cancer

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxPWC1ySFhRZTZUVXFsNmJNQTc5allQejRoQUFzeWdsWE9xcXJKUEk0SmVHUVQ4RXdqZ0J5SUlBc0xJSDBBU0M2UndXM0ZpNnpwOXZwYm9vYl9EREQ0Vk1rd29zMmd4d0c2dkJHdXRGVUtMa3MxWW5Mc1NqTkZ6dmlXSVJJTFdSWUw2bjd1ZGIza2E?oc=5" target="_blank">ADC FG-3246 May Show Promise in Advanced Prostate Cancer</a>  <font color="#6f6f6f">Cure Today</font>

Read Full StoryMore like this
Cartesian data add to progress, questions for CAR-T in autoimmune disease
BioPharma Diveworld

Cartesian data add to progress, questions for CAR-T in autoimmune disease

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxPdTVDbnJJMmd4NzdnM2tmRU0zRGNBMXctMUMzRG1PTXZ3U054VjVMalRhbXZGSC1oNFhkSUZXUWxBQ3NDc0hHYjZFcHZwa0hDLWJtZnpzakJGUHEwNTVzNjdPYmVWR1VZdW1lMnVETTI5WXJ0ZlBqS2N5M1VmdHJWZXdtUVBuSDkxcmVHUU9NeXhkLTJTdDJPem1zUG9JZw?oc=5" target="_blank">Cartesian data add to progress, questions for CAR-T in autoimmune disease</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Artiva prices $167M IPO, riding optimism for autoimmune cell therapy
BioPharma Diveworld

Artiva prices $167M IPO, riding optimism for autoimmune cell therapy

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNRTJTNjBONW9TbjcwWnM5eWh2MVIwZlRQZUJoSkt4WWJEdk9SZHZ1UUExRG10MlR5X2ZxX2xRbUhNZU1lc0pLNW5NejhJREQzczFoaFRqc2RfY1ltTUJESENDTmx2LTlpM3FydlpfRjJCSUIydjVOMXRmYkw5SVpEeFJQdzdyNkpnMXJMcnNZanRvb0w1bE4yYUhuUkthY0piTkpRSg?oc=5" target="_blank">Artiva prices $167M IPO, riding optimism for autoimmune cell therapy</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Kyverna swaps CEOs, leaning on Kite veterans to lead ‘next chapter’
BioPharma Divegeneral

Kyverna swaps CEOs, leaning on Kite veterans to lead ‘next chapter’

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxOZ2RTd3hZZ3RoeFZFZE1KVTJ6czk2SmlJb1hldDlTbEZxeERQR0YwSFI5dHFiSGUzRWcydkxVWXpnaWdqeU0zUW5ETk9ZTVctc3N1UDBfZTQ4QjQ0WTQxSEltWG1hX3U1YlB3UmVhdnhWdjFzd2tyX1pVZ2VmQkFvYlgyT3Z6MW1Lb3ZzN3gtdjlmQlE?oc=5" target="_blank">Kyverna swaps CEOs, leaning on Kite veterans to lead ‘next chapter’</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
IGM’s autoimmune pivot backfires as top drug disappoints in testing
BioPharma Diveworld

IGM’s autoimmune pivot backfires as top drug disappoints in testing

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQWTNKekxKbjJuLWE5VGlIb1M0M1FGLWJlU0t5azdnTWNvZG1qODBWb292ZFBsdy1NMXdtcndpVGg0NlNoMlo2TkZSbVJia3JIWnVaRVYycldPMnNyOVROdy1ucHVSUnlrWklNQ3N2dDJiSzBVZTQ5OXFsNWpJOTlHVmVsLU91RUNWZnlNNTZ1bXhFSVdSbUl5cHMtZ0JiUVBrTnNXUlA3RnA?oc=5" target="_blank">IGM’s autoimmune pivot backfires as top drug disappoints in testing</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Bristol’s $1.5B Orbital buyout extends ‘in vivo’ cell therapy deal streak
BioPharma Divegeneral

Bristol’s $1.5B Orbital buyout extends ‘in vivo’ cell therapy deal streak

<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxORV9TVVQwQXg4NXJFZGlQSmNsb2hsZjhyUXV5cEJxUVlzRV9VUzc0OXdOb2VFd19EdXRXYjZkUVo5WXdNT3lyTGJKQWEzaHBJcmZtcGItd0cwcm15RFlsYUNkRk9vNmN5ODg1Q2F3a0k3aGZtS0p4OG5pbzNCMUllT1J1MGN6RzE0UlVxUkRtdUNTQk1VTFU0Qw?oc=5" target="_blank">Bristol’s $1.5B Orbital buyout extends ‘in vivo’ cell therapy deal streak</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Cullinan doubles down on bispecifics for autoimmune disease with Genrix deal
BioPharma Diveworld

Cullinan doubles down on bispecifics for autoimmune disease with Genrix deal

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxPelFsazlYUXRsMjRubHFuM3NrempvbDRuZFh4eGw2V01ncGx4Vy1kRThsQ21ZODRsakpaVHRkOTJvMUctRnNmS2dtd1liTWpsdzNQd2Vmdy0yNjNSY2FjUVRLbzhRWXBmaHhkbzlyTEhWcUtQV1JEZTJnNk1yNEI0ODZ6b3FHWUNiVkszTl9FNXNZZklYYms0T2tRZXdfdw?oc=5" target="_blank">Cullinan doubles down on bispecifics for autoimmune disease with Genrix deal</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
Biogengeneral

Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxPUTNlaEd0WkprT2pMLVYwMWllWHZrY2gzd0VtXzJZVW1CcDJpcU8xbjB5ZWM0Z0FWT3Q0QXNjOGttZmhWUHNRQ3lELUx3U0NiNGtRSlVzYVFFanNXTEg0cGhhTFp5WGlzbGU3NVRfN3Itdzc0aHA3QUVZeE5UZmlVdjZVVGsxcmk2TFVzQ0pMRmZ1MXYwQ2h1YjY2d1FwQ2M4YUVvdHJvb21qV1o0Rzcxb254Vzl3UXVELVdwag?oc=5" target="_blank">Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025</a>  <font color="#6f6f6f">Biogen</font>

Read Full StoryMore like this
New salary survey to showcase the promise of horticulture careers
Morning Ag Clipsgeneral

New salary survey to showcase the promise of horticulture careers

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxOTlIxdmhMMlJkZC1nUjVVQlZVd0M4YnRmSXIxRjRVY1BfVmdDai11cS1LcUo4VVhzSDlTWUMwR3ExMS0yZEo2VE4xcDBGVmxDRGNSSzlhNUZEeHB0TVZEME54T3BkcGhVbEltOXpTT1hfUVlYUC04blZ4cHVTTU5uX1F1cjlPaGRwZkJweFhKQjg2SUFXbDduUHdQUGtIdw?oc=5" target="_blank">New salary survey to showcase the promise of horticulture careers</a>  <font color="#6f6f6f">Morning Ag Clips</font>

Read Full StoryMore like this
Nkarta to lay off staff, senior leadership, in bid to advance autoimmune cell therapy
BioPharma Diveworld

Nkarta to lay off staff, senior leadership, in bid to advance autoimmune cell therapy

<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxNZ0FabFdQQ2wxX1BZd3lqdnhYUmtDNzY2NXJjYjRFQ0dqa21tMFlqQlN6bGNzZzVuaEdCVlJFT2wxNlVMSHlMS2wza1MtazREb3E5UDRPVU5NdFQ4WjdVeTJlaEJmTW1kSUdYRHNiY2JwZUZsNXZsbG1OeXFuemV2SHBidXJuSFRWTWx4NlFVY09USnFPTC1EellRRQ?oc=5" target="_blank">Nkarta to lay off staff, senior leadership, in bid to advance autoimmune cell therapy</a>  <font color="#6f6f6f">BioPharma Dive</font>

Read Full StoryMore like this
"New data showcase promise" — Live Google News Trends & Headlines